Publication:
Paclitaxel carboplatin in elderly patients with advanced non-small cell lung cancer

dc.contributor.buuauthorKanat, Özkan
dc.contributor.buuauthorÇubukcu, Erdem
dc.contributor.buuauthorÇUBUKÇU, ERDEM
dc.contributor.buuauthorAksoy, Savas
dc.contributor.buuauthorÇubukcu, Sinem
dc.contributor.buuauthorÇUBUKÇU, SİNEM
dc.contributor.buuauthorCanhoroz, Mustafa
dc.contributor.buuauthorKaradağ, Oya
dc.contributor.buuauthorAlkış, Nihan
dc.contributor.buuauthorManavoğlu, Osman
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı.
dc.date.accessioned2024-09-06T06:11:37Z
dc.date.available2024-09-06T06:11:37Z
dc.date.issued2012-07-01
dc.description.abstractAim: In this study, the safety and tolerability of paclitaxel and carboplatin (PC) regimen in elderly patients with advanced non -small cell lung cancer (NSCLC) was investigated. Material and Method: Elderly patients (ages a70 years) who received PC for stage III (n=111 or IV (n=34) NSCLC were evaluated retrospectively. Results: There were 43 males and 2 females, with a median age of 75.5 (range, 70-62). The response rate was 40%. The median overall survival time and progression-free survival time was 13 months and 8.5 months, respectively. One-year survival rate was 51%. Treatment was well tolerated by the patients. The most frequent side effect observed was grade 3 or 4 neutropenia (57.795). There was no treatment related death. Discussion: PC regimen may be a good alternative for the treatment of elderly patients with advanced NSCLC.
dc.identifier.doi10.4328/JCAM.705
dc.identifier.endpage295
dc.identifier.issn1309-0720
dc.identifier.issue3
dc.identifier.startpage293
dc.identifier.urihttps://doi.org/10.4328/JCAM.705
dc.identifier.urihttps://hdl.handle.net/11452/44359
dc.identifier.volume3
dc.identifier.wos000215547400012
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherDerman Medical Publ
dc.relation.journalJournal Of Clinical And Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNon-small cell
dc.subjectLung
dc.subjectElderly
dc.subjectChemotherapy
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectMedicine, general & internal
dc.subjectGeneral & internal medicine
dc.titlePaclitaxel carboplatin in elderly patients with advanced non-small cell lung cancer
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationf971677f-09c5-4463-bf01-3c6341fbe5f7
relation.isAuthorOfPublication375ef438-7ff8-4a42-97a4-74096fac117f
relation.isAuthorOfPublication.latestForDiscoveryf971677f-09c5-4463-bf01-3c6341fbe5f7

Files

Collections